Cargando…
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
BACKGROUND: Multiple sclerosis is a neuroinflammatory demyelinating and neurodegenerative disease of the central nervous system characterized by recurrent and progressive demyelination/remyelination cycles, neuroinflammation, oligodendrocyte loss, demyelination, and axonal degeneration. Cyclic phosp...
Autores principales: | Yamamoto, Shinji, Yamashina, Kota, Ishikawa, Masaki, Gotoh, Mari, Yagishita, Sosuke, Iwasa, Kensuke, Maruyama, Kei, Murakami-Murofushi, Kimiko, Yoshikawa, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521126/ https://www.ncbi.nlm.nih.gov/pubmed/28732510 http://dx.doi.org/10.1186/s12974-017-0923-5 |
Ejemplares similares
-
Correction to: Protective and therapeutic role of 2-carbacyclic phosphatidic acid in demyelinating disease
por: Yamamoto, Shinji, et al.
Publicado: (2018) -
2-Carba cyclic phosphatidic acid inhibits lipopolysaccharide-induced prostaglandin E2 production in a human macrophage cell line
por: Shibaike, Yuki, et al.
Publicado: (2019) -
2-carba cyclic phosphatidic acid suppresses inflammation via regulation of microglial polarisation in the stab-wounded mouse cerebral cortex
por: Hashimoto, Kei, et al.
Publicado: (2018) -
Cyclic phosphatidic acid relieves osteoarthritis symptoms
por: Gotoh, Mari, et al.
Publicado: (2014) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)